Baker E M, Cheek T R, Burgoyne R D
Biochim Biophys Acta. 1985 Sep 30;846(3):388-93. doi: 10.1016/0167-4889(85)90010-2.
The role of cAMP in the control of secretion from bovine adrenal chromaffin cells was examined using the adenylate cyclase activator, forskolin. Treatment of chromaffin cells with forskolin resulted in a rise in cAMP levels. Forskolin inhibited catecholamine release elicited by carbamylcholine or nicotine but had no effect on secretion evoked by 55 mM K+. Inhibition of carbamylcholine-stimulated release by forskolin was half-maximal at 10 microM forskolin. The inhibition by forskolin of secretion evoked by carbamylcholine was at a step distal to the rise in intracellular free calcium concentration ([Ca2+]i), since this rise was not inhibited by forskolin, which itself produced a small rise in [Ca2+]i. The results suggest that secretion evoked by carbamylcholine is due to the activation of an additional second messenger pathway acting with the rise in [Ca2+]i. This additional pathway may be the target for cAMP action.
使用腺苷酸环化酶激活剂福斯可林研究了环磷酸腺苷(cAMP)在调控牛肾上腺嗜铬细胞分泌中的作用。用福斯可林处理嗜铬细胞会导致cAMP水平升高。福斯可林抑制了由氨甲酰胆碱或尼古丁引发的儿茶酚胺释放,但对55 mM钾离子诱发的分泌没有影响。福斯可林对氨甲酰胆碱刺激的释放的抑制作用在10 microM福斯可林时达到半数最大抑制浓度。福斯可林对氨甲酰胆碱诱发的分泌的抑制作用发生在细胞内游离钙浓度([Ca2+]i)升高的下游步骤,因为这种升高不受福斯可林抑制,而福斯可林本身会使[Ca2+]i略有升高。结果表明,氨甲酰胆碱诱发的分泌是由于与[Ca2+]i升高协同作用的另一条第二信使途径的激活。这条额外的途径可能是cAMP作用的靶点。